Appointments

Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

  • Integrative Research Centers

    Center for DNA Damage and Repair

    Geoffrey Shapiro, MD, PhDCDDR Clinical Director Geoffrey Shapiro, MD, PhD, is an expert in early anti-cancer drug development. 
    Alan D'Andrea, MDCDDR Director Alan D'Andrea, MD, is an expert in the area of DNA repair and genomic stability. 

    The Center for DNA Damage and Repair (CDDR) explores the various DNA repair defects in human cancers which underlie genomic instability. A better understanding of these DNA repair defects will lead to improved diagnostic methods for predicting the best course of cytotoxic chemotherapy and radiation for a given cancer patient ("precision" or "personalized" medicine). Studies conducted in the Center will also facilitate the development of new classes of anti-cancer drugs, such as DNA Repair inhibitors and Cell Cycle inhibitors.

    The Center for DNA Damage and Repair will function as a central resource for Dana-Farber Cancer Institute in supporting unbiased and hypothesis-driven cancer research involving DNA repair biology. CDDR will collaborate with both basic researchers and clinicians to develop innovative research involving DNA damage and DNA repair experimentation.

    CDDR employs a wide range of technologies relevant to the measurement of DNA damage response in primary human cancers and cell lines, including cytotoxicity measurements, radiation sensitivity testing, and proteomic biomarker measurements. These methodologies will be especially helpful to Dana-Farber researchers working in related fields of cancer biology, as well as to the Institute's clinical investigators developing new drugs for cancers with specific underlying DNA repair defects. The CDDR includes faculty and staff scientists with a broad knowledge of DNA repair biology, biomarker development, and drug testing.

    CDDR is led by Director Alan D'Andrea, MD, and Clinical Director Geoffrey Shapiro, MD, PhD, who oversee the overall basic scientific and translational activities of the Center and report to the Chief Scientific Officer/Office of the President and the CDDR Oversight Committee. Drs. D'Andrea and Shapiro work with a larger faculty team of PIs from Dana-Farber's Departments of Medical Oncology, Pediatric Oncology, and Radiation Oncology.

  •   Email
  •   Print
  •   Share
  • Find a Researcher

    Search by last name:

  • Personalized Medicine Research

    • Barrett Rollins, MD, PhD and Neil Lindeman, MDLearn about Profile, a comprehensive somatic genotyping study that focuses on the development of targeted treatments for every person with cancer.